Progressive Scapular-Focused Exercises for Neck Pain Related to Scapular Dysfunction
NCT07932197, Not applicable, Not yet recruiting, University of Phayao
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Progressive Scapular-Focused Exercises for Neck Pain Related to Scapular Dysfunction | ClinicalTrials.gov |
| NCT number | NCT07932197 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 48 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | University of Phayao | ClinicalTrials.gov |
| Conditions | Neck Pain, Scapular Dyskinesis | ClinicalTrials.gov |
| Interventions | Progressive Scapular-Focused Exercise Program, Routine Physical Therapy Treatment | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Neck pain intensity | At baseline, immediately post-intervention, and at 3-month follow-up. | The average intensity of neck pain will be assessed using a 0-10 cm visual analogue scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain. | ClinicalTrials.gov |
| Primary | Neck disability | At baseline, immediately post-intervention, and at 3-month follow-up. | The Neck Disability Index (NDI) will be used to assess the impact of neck pain on daily activities and self-reported disability. The questionnaire consists of 10 items, with a total score ranging from 0 to 50. Higher scores indicate greater neck-related disability. | ClinicalTrials.gov |
| Primary | Scapular muscle strength | At baseline, immediately post-intervention, and at 3-month follow-up. | Scapular muscle strength (lower trapezius and serratus anterior) will be assessed using a handheld dynamometer. | ClinicalTrials.gov |
| Primary | Scapular position | At baseline, immediately post-intervention, and at 3-month follow-up. | Scapular position will be assessed using the Lateral Scapular Slide Test. | ClinicalTrials.gov |
| Secondary | Cervical range of motion | At baseline, immediately post-intervention, and at 3-month follow-up. | Cervical range of motion will be measured in degrees during flexion, extension, left and right lateral flexion, and left and right rotation. | ClinicalTrials.gov |
| Secondary | Upper limb disability | At baseline, immediately post-intervention, and at 3-month follow-up. | Upper limb disability will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The questionnaire consists of 30 items assessing symptoms and functional limitations of the arm, shoulder, and hand. Scores range from 0 to 100, with higher scores indicating greater disability. | ClinicalTrials.gov |
| Secondary | Global perceived benefit of treatment | At baseline, immediately post-intervention, and at 3-month follow-up. | Global perceived benefit of treatment will be assessed using a 7-point Likert scale, ranging from 1 (very dissatisfied) to 7 (very satisfied). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)